ENTA R&D to Revenue
Enanta Pharmaceuticals Inc · R&D to Revenue
ENTA R&D to Revenue
Latest reported154.09%period ending
ENTA Quarterly R&D/Revenue (0.00% → 154.09%)
Latest values, visible window
High-resolution chart · PNG
ENTA r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 154.0915% | |
| 113.3108% | |
| 112.0548% | |
| 157.4149% | |
| 148.5749% | |
| 188.0276% | |
| 163.0757% | |
| 210.7072% | |
| 159.9355% | |
| 208.6607% | |
| 202.0274% | |
| 191.0363% | |
| 227.5408% | |
| 244.2709% | |
| 173.4238% | |
| 171.2654% | |
| 200.6777% | |
| 224.8718% | |
| 175.5968% | |
| 207.6182% | |
| 217.3233% | |
| 206.1693% | |
| 115.5058% | |
| 155.2452% | |
| 185.9326% | |
| 118.0709% | |
| 62.3512% | |
| 75.4565% | |
| 77.6726% | |
| 86.1825% | |
| 49.907% | |
| 40.061% | |
| 49.7485% | |
| 48.773% | |
| 47.1332% | |
| 21.7498% | |
| 205.1258% | |
| 145.1501% | |
| 120.2458% | |
| 89.5569% | |
| 77.157% | |
| 70.3091% | |
| 18.6459% | |
| 48.8971% | |
| 53.9098% | |
| 9.3573% | |
| 5.8311% | |
| 197.2696% | |
| 10.8273% | |
| 218.6111% | |
| 477.3796% | |
| 318.7546% | |
| 244.9363% | |
| 322.3244% | |
| 17.2224% | |
| 229.0097% | |
| 193.7451% | |
| 8.9238% | |
| 360.5938% | |
| 0% |